Background {#Sec1}
==========

*Toxoplasma gondii* is a widespread zoonotic parasite that infects all warm-blooded animals and humans \[[@CR1]\]. Felids are its definitive hosts and excrete oocysts in their feces \[[@CR2], [@CR3]\], and the oocyst burden in areas where cats selectively defecate is high \[[@CR4]\]. Animals and humans acquire infections mainly by ingesting food or water contaminated with sporulated oocysts and tissue cysts \[[@CR5]\]. Although most infections are asymptomatic, reproductive losses in animals \[[@CR6]\] and multiple disorders, that include cognitive impairment and fatal encephalitis in humans could come about \[[@CR7], [@CR8]\]. Additionally, there are reports of associations between *T. gondii* infections with schizophrenia \[[@CR9], [@CR10]\], bipolar disorder \[[@CR11], [@CR12]\], suicide \[[@CR13]\], epilepsy \[[@CR14]\] and traffic accidents \[[@CR15], [@CR16]\].

Despite *T.gondii* being an important zoonotic pathogen, there is no national survey that addressed the multiple disorders it causes in humans, its impact in animal production, its temporal and spatial distribution and the risk factors associated with the occurrence of the disease in Ethiopia. The objectives of this study were to estimate the prevalence of *T. gondii* infection in cats, food animals and humans in Ethiopia, and assess the potential risk factors of infection.

Methods {#Sec2}
=======

The study was conducted according to the PRISMA guideline (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) \[[@CR17]\]. The PRISMA checklist was used to ensure inclusion of relevant information in the analysis (see Additional file [1](#MOESM1){ref-type="media"}).

Literature search {#Sec3}
-----------------

Published studies were searched in Medline. Non-Medline indexed articles were searched in Google Scholar and the lists of references of articles. Toxoplasm\* and Ethiopia were the main MeSH terms used in electronic searches. Additional searches were done by using the main MeSH terms, Boolean operators, prevalence, incidence, cats, cattle, sheep, goats, camels, pigs, chicken and humans. The last search was done on December 23, 2014. Full text articles were downloaded or obtained from the library of the school of Medicine, College of Health Sciences, Addis Ababa University, and from Dr. Jitender P. Dubey.

Selection of studies {#Sec4}
--------------------

A study was eligible for quantitative analyses if (i) it was published in English, (ii) it was cross-sectional, (iii) the methods were coprological and/or serological \[Sabin Feldman dye test (SFT), modified agglutination test (MAT), modified direct agglutination test (MDAT), direct agglutination test (DAT), enzyme linked immunosorbent assay (ELISA) and latex agglutination test (LAT)\], and (iv) the sample size was greater than 35. Studies were excluded if the titles and abstracts were not relevant to the outcomes of interest or did not fulfill the eligibility criteria.

Data extraction {#Sec5}
---------------

From each eligible study, the following data were extracted: the first author, year of publication, year of study, location, climatic zone, altitude, study design, sample size, species, sex, age group, test methods and the number of positive samples. In addition, from studies on humans, the following were extracted: setting (hospital/non-hospital), pregnancy status (pregnant/non pregnant), HIV status (HIV positive/HIV negative), residence (urban/rural), behavior (apparently normal/abnormal), raw meat (consumer/non consumer), raw vegetable (consumer/non consumer), presence of cats in the household/contact (yes/no) and water source (pipe/others).

Data analysis {#Sec6}
-------------

Data on cats, food animals and humans were analyzed separately. The study level estimates were transformed to logit event estimates \[[@CR18], [@CR19]\] by the following formula: lp = ln \[p/ (1 − p)\], where lp = logit event estimate; ln = natural logarithm; p = study level estimate. The variances of the estimates were calculated by the following formula: v (lp) = 1/(np) + 1/ \[n (1 − p)\], where v = variance and n = sample size.

Bias and heterogeneity analyses {#Sec7}
-------------------------------

The qualities of the study methods (study design and serological tests) were used to assess the within study biases. The across study bias (small study effects) was examined by funnel plots, and the statistical significance was assessed by the Egger's regression asymmetry test \[[@CR20]\]. The Duval and Tweedie non-parametric 'fill and trim' linear random method was used to calculate unbiased estimates \[[@CR21]\]. The heterogeneities of study level estimates were assessed by Galbraith plot \[[@CR22]\] and Cochran's Q test. A non significant heterogeneity was accepted if the ratio of Q and the degree of freedom (Q/df) was less than one. The percentage of the variation in prevalence estimates attributable to heterogeneity was quantified by the inverse variance index (I^2^), and I^2^ values of 25 %, 50 % and 75 % were considered as low, moderate and high heterogeneity, respectively \[[@CR23]\]. Subgroup analyses were done if the heterogeneities were moderate to high. A study was included in a subgroup analysis if the number of individuals (n) was more than 25 % of the mean of the subgroup.

Pooling and sensitivity tests {#Sec8}
-----------------------------

The DerSimonian and Laird random effects model was used to pool logit event estimates \[[@CR24]\]. Pooled logit estimates were transformed to prevalence estimates (p) by the following formula: *p* = e^lp^/ (e^lp^ + 1): where e = the base of natural logarithm. Single study omitted influence analyses were done to test the robustness of a pooled estimate, and a study was considered to have no influence if the pooled estimate without it was within the 95 % confidence limits of the overall mean. The Z test was used to test whether a pooled estimate significantly differs from zero or not. The Yates corrected Chi Square test was used to test the significance of a difference between estimates \[[@CR25], [@CR26]\]. Alpha was set at 0.05.

Microsoft Office Excel 2007 was used to transform study level estimates to logit event estimates, and to back transform pooled logit event estimates to prevalence estimates. Epi info^TM^ (Version 3.5.1, Center for Disease Control, CDC, USA) was used to compare groups. Stata (Version 11.1, Stata Corp, College Station, Texas) was used in all other analyses.

Results {#Sec9}
=======

Search results and eligible studies {#Sec10}
-----------------------------------

Figure [1](#Fig1){ref-type="fig"} shows the search results. A total of 63 studies were found of which 18 were excluded based on the titles and abstracts. Of the studies screened for eligibility, 12 were excluded due to the following reasons: one was not available; two were abstracts; the sample size was 20 in one; the data was inconsistent in one; the diagnosis was established on the basis of clinical signs in one; IHAT was used in three, and the methods were not described in three studies. A total of 32 full-text studies were used for quantitative analyses \[[@CR27]--[@CR58]\].Fig. 1Flow diagram of the selection of eligible studies

Characteristics of the eligible studies {#Sec11}
---------------------------------------

On the whole, data from 5689 animals (124 cats, 1950 sheep, 2102 goats, 726 chickens, 402 pigs and 385 camels) and 5718 humans from several regions of Ethiopia were analyzed (Table [1](#Tab1){ref-type="table"}).Table 1Characteristics of the eligible studiesAuthorYear of studyLocationHostMethodNumberPositive (%)Zewdu et al. \[[@CR27]\]2010--2011CEGoatELISA927183 (19.74)Gebremedhin et al. \[[@CR28]\]2010--2011CESheepELISA1030357 (34.66)Teshale \[[@CR29]\]2005--2006CSESheep, goatMDAT641480 (74.88)Demissie and Tilahun \[[@CR30]\]2000--2001CESheep, goatMDAT468159 (33.97)Negash et al. \[[@CR31]\]1999--2000CESheep, goatMDAT/ELISA17475 (43.10)Gebremedhin and Gizaw \[[@CR32]\]2013--2014SESheep, goatELISA18448 (26.09)Gebremedhin et al. \[[@CR33]\]2011--2012CESheep, goatDAT628111 (17.68)Gebremedhin et al. \[[@CR34]\]2012--2013CECamelMAT385187 (48.57)Tilahun et al. \[[@CR35]\]2012CEChickenMAT12548 (38.40)Gebremedhin et al. \[[@CR36]\]2012--2013CEChickenMAT601183 (30.45)Gebremedhin et al. \[[@CR37]\]2014CEPigDAT402129 (32.09)Dubey \[[@CR38]\]2011CECatMAT3633 (91.67)Tiao \[[@CR39]\]2012CECatMAT4841 (85.42)Negash et al. \[[@CR31]\]1999--2000CECatCoprology405 (12.5)Dubey \[[@CR38]\]2011CECatCoprology368 (22.22)Mellbin and Vahlquist \[[@CR40]\]nrWCSEhumanSFT267102 (38.20)De Roever--Bonnet \[[@CR41]\]nrCEhumanSFT9947 (47.47)Guebre Xabier et al. \[[@CR42]\]1990CSEhumanELISA919673 (73.23)Eshete et al. \[[@CR43]\]nrCEhumanELISA9419 (20.21)Woldemichael et al.\[[@CR44]\]1995--1996CEhumanSFT/LAT340268 (78.82)Negash et al. \[[@CR45]\]1999--2000CEhumanMDAT6539 (60.00)Yimer et al. \[[@CR46]\]nrCEhumanELISA279270 (96.77)Shibre et al. \[[@CR47]\]^a^2005CEhumanELISA9080 (88.89)Shimelis et al. \[[@CR48]\]2007CEhumanELISA330297 (90.00)Tedla et al. \[[@CR49]\]^a^2009CEhumanELISA456434 (95.18)Zemene et al. \[[@CR50]\]2011SEhumanELISA201163 (81.09)Gebremedhin et al. \[[@CR51]\]2010--2011CEhumanELISA425346 (81.41)Aleme et al. \[[@CR52]\]2011--2012CEhumanELISA150141 (94.00)Walle et al. \[[@CR53]\]nrNEhumanELISA204161 (78.92)Muluye et al. \[[@CR54]\]2012--2013NEhumanLAT170130 (76.47)Tadesse et al. \[[@CR55]\]2012NEhumanLAT422171 (40.52)Endris et al. \[[@CR56]\]2010--2011NEhumanLAT385341 (88.57)Zeweld et al. \[[@CR57]\]2012--2013NEhumanELISA65151 (7.83)Yohannes et al. \[[@CR58]\]2013SEhumanELISA170150 (88.24)CE, Central Ethiopia; CSE, Central and Southern Ethiopia; DAT, direct agglutination test; ELISA, enzyme linked immunosorbent assay; LA, latex agglutination test; MAT, modified agglutination test; MDAT, modified direct agglutination test; MDAT/ELISA, modified direct agglutination test and enzyme linked immunosorbent assay; n, sample size; NE, Northern Ethiopia; nr, not reported; SE, Southern Ethiopia; SFT, Sabin-Feldman dye test; WCSE, Western, Central and Southern Ethiopia^a^Data on *T.gondii* infection was collected before the trials

Bias and heterogeneity assessment {#Sec12}
---------------------------------

All studies on animals were cross-sectional, and the serological tests were ELISA, DAT, MDAT and MAT. All studies on humans were cross-sectional and IgG seroprevalence was examined by using ELISA, LAT, SFDT and MDAT. According to the manufacturers of the kits, the sensitivities and specificities of the tests were \> = 92 %, and \> = 95 %, respectively. As the sensitivity and specificity of LAT was lower than those of the other tests, a subgroup analysis of the estimates of human studies that used LAT vs. other tests did not yield a statistically significant difference (p \> 0.05). The funnel plots (Fig. [2](#Fig2){ref-type="fig"}) and the bias coefficients in both food animal \[b = 0.54 (95 % CI = −19.27, 20.35; p \> 0.05), and human \[b = 5.45 (95 % CI = −4.67, 15.57; p \> 0.05) studies did not suggest the presence of bias, and no theoretical missing study was incorporated by the Duval and Tweedie non-parametric method. The percentages of the variations in prevalence estimates attributable to heterogeneities were zero, 97.6 % and 98.6 % in cat, food animal and human studies, respectively.Fig. 2Funnel plots of the logit IgG seroprevalence estimates (lp) in food animals (**a**) and humans (**b**)

Pooled prevalence estimates {#Sec13}
===========================

Cats {#Sec14}
----

The pooled prevalence of seropositive cats was 87.72 % (95 % CI = 78.63, 93.28; p \< 001), I^2^ = 0. The pooled prevalence of oocyst shedder cats was 17.51 % (95 % CI = 9.77, 29.36; p \< 001), I^2^ = 19 %.

Food animals {#Sec15}
------------

Figure [3](#Fig3){ref-type="fig"} shows a forest plot of the IgG logit event estimates in food animals. The pooled estimates by potential risk factors are presented in Table [2](#Tab2){ref-type="table"}. The overall prevalence of *T. gondii* infection was 35.5 % (95 % CI = 25.96, 46.36), and the estimates for ruminants and non-ruminants did not differ significantly (p \> 0.05). In subgroup analyses, the pooled seroprevalence of *T. gondii* in small ruminants was 34.59 % (95 % CI = 21.08, 51.12; p \> 0.05), I^2^ = 98.9 %, with a higher occurrence in sheep than in goats, in females than in males, and in adults than in young animals. All single study omitted estimates lie within the 95 % confidence intervals of the respective overall means of each group.Fig. 3Forest plot of the logit IgG seroprevalence estimates (lp) in food animalsTable 2Pooled estimates of T. gondii in food animals by potential risk factorsRisk factorsp (95 % CI)Z-*p*Q/dfQ-*p*I^2^*X* ^2^Y-*p*OR (95 % CI)All animalsOverall35.50 (25.96,46.36)0.00956.970.00098.2Ruminant32.54 (22.51,44.47)0.00532.410.00098.10.010.9331.01 (0.87,1.16)Non-ruminant32.34 (28.88,35.99)0.0001.50.22333.4Small RuminantsOverall34.59 (21.08, 51.12)0.06788.690.00098.9Sheep33.51 (26.06, 41.90)0.00010.710.00090.710.240.0011.25 (1.09,1.43)Goat28.80 (11.17, 56.54)0.129100.390.00099Female29.38 (23.06, 36.63)0.0009.730.00089.723.950.0001.70 (1.37,2.12)Male19.67 (10.80, 33.09)0.00011.480.00091.3Adult34.30 (24.96, 45.07)0.00518.790.00094.7100.500.0003.06 (2.43,3.86)Young14.62 (10.93, 19.26)0.0002.350.07057.4Midland ^a^53.32 (36.12, 69.76)0.71016.090.00093.845.430.0002.27 (1.78,2.91)Highland33.45. (29.78, 37.36)0.0000.280.5970Lowland14.99 (8.0, 26.39)0.000.I^2^, inverse variance index; OR, odds ratio; Q, Cochran's *X* ^2^; Y-*p,* probability of Yates test; Z-*p,* probability of Z test^a^The comparison was between midland and highland estimates

Humans {#Sec16}
------

Figure [4](#Fig4){ref-type="fig"} shows a forest plot of the logit estimates in humans. The pooled prevalence estimates by potential risk factors are presented in Table [3](#Tab3){ref-type="table"}. The overall pooled prevalence was 74.73 % (95 % CI = 61.85, 84.36). The pooled estimate was affected by sex, age, pregnancy, status, cat contact/ possession and residential area but not by raw meat and raw vegetable consumption habits, and source of water. The pooled seroprevalence in patients with behavioral disorders (schizophrenia/bipolar disorder) was 93.88 % (95 % CI = 81.47, 98.16; p \< 001), I^2^ = 88.2 %. All single study omitted estimates lie within the 95 % confidence intervals of the respective overall means of each group.Fig. 4Forest plot of the logit IgG seroprevalence estimates (lp) in humansTable 3Pooled estimates of T. gondii in humans by potential risk factorsRisk factorsp (95 % CI)Z-*p*Q/dfQ-pI^2^*X* ^2^Y-*p*OR (95 % CI)Overall74.73 (61.85,84.36)0.00070.40.00098.6SexMale73.54 (41.95, 91.44)0.13751.10.0009837.170.0001.65 (1.40,1..95)Female62.74 (40.08,80.91)0.26969.40.00098.6AgeAdults69.87 (47.50,85.59)0.08080.20.00098.851.060.0001.95 (1.62,2.36)Children54.34 (24.81,81.11)0.79054.80.00098.2PregnancyPregnant62.55 (29.88, 86.74)0.46256.80.00098.2152.830.0003.96 (3.15,4.97)Non-pregnant29.59 (0.75, 95.87)0.672197.80.00099.5CatContact85.96 (74.12, 92.90)0.00013.60.00092.664.100.0002.53 (2.00,3.20)No contact70.70 (53.74, 83.37)0.01827.40.00096.4ResidenceUrban82.58 (73.63, 88.93)0.0002.70.00096.364.040.0002.06 (1.71,2.47)Rural69.80 (52.40, 82.91)0.02719.80.00094.9MeatRaw C^a^77.22 (63.85, 86.68)0.00018.30.00094.50.650.4211.10 (0.88,1.36)Raw NC^b^75.58 (51.22.90.11)0.04036.00.00097.2VegetableRaw C^a^75.44 (53.00, 89.33)0.02831.80.00096.91.450.2291.19 (0.90,1.56)Raw NC^b^72.23 (35.92, 92.34)0.22236.60.00097.3WaterNon pipe86.65 (82.17, 90.13)0.0000.540.58501.360.2431.30 (0.85,2.00)Pipe83.45 (76.73, 88.52)0.0006.40.00084.2HIVPositive81.06 (50.07, 94.81)0.0577.70.00098.70.260.6091.06 (0.87,1.29)Negative80.17 (72.47, 86.13)0.0006.70.00085.0I^2^, inverse variance index; OR, odds ratio; Q, Cochran's *X* ^2^; Y-*p,* probability of Yates test; Z*-p* probability of Z test^a^Consumers^b^Non-consumers

Discussion {#Sec17}
==========

The moderate to high inverse variance indexes of the study level estimates in food animals and humans reported here are suggestive of potential variations that could have been due to cat densities, environmental and societal factors \[[@CR59], [@CR60]\].

The prevalence of *T. gondii* in cats in Ethiopia was high. Ethiopian cats live outdoors, hunt, feed on scraps and garbage-thus more exposed to the parasite \[[@CR3]\]. In a study from California, USA, the annual environmental burden per square meter was estimated to be in the range of 94 to 4671 oocysts, based on a low prevalence (0.9 %) of oocysts in cat feces \[[@CR61]\]. Therefore, if we assume 17.51 % oocyst shedder cats in Ethiopia, and 100 million oocysts per shedder \[[@CR1]\], the environmental burden in urban residential areas where cats abound is apparently high.

The overall pooled estimate in small ruminants was considerable (34.59 %), and the odds of infection was three times greater in adults than in young small ruminants. The higher occurrence of *T.gondii* infection in adults compared to young animals is in agreement with results of studies carried out elsewhere \[[@CR62], [@CR63]\]. The estimate demonstrates the potential of *T. gondii* as a cause of reproductive wastage in small ruminants, and the risk associated with the consumption of raw products derived from small ruminants \[[@CR64], [@CR65]\].

The substantially high prevalence of *T. gondii* infections in humans could be due to the uncontrolled movement of cats, the substandard living circumstances, and the unhygienic life styles and habits that favor the transmission of the parasite from either felids or food animals. Comparison of the present estimate with estimates for sub-Saharan African countries (SSA) is difficult because national survey reports or meta-analytical studies are scarce. However, the prevalence of *T. gondii* infection in Ethiopian women is apparently higher than estimates for most developed countries (4 % in South Korea to 11 % in USA) \[[@CR60]\]. Therefore, assuming three million live births each year \[[@CR66]\], and a conservative estimate of 0.1 % birth prevalence of congenital infections \[[@CR67], [@CR68]\], the number of congenitally infected neonates per annum could be about 3000.

*T.gondii* infection was higher in urban than in rural inhabitants and in individuals with cats in the household or had contact with cats. The cat population per unit area appears to be higher in the urban than in the rural areas because of the relatively better feed resource in the former than the latter, and as cats roam in search of food a single cat could be a source of infection to several neighboring urban households.

The high prevalence of *T.gondii* in HIV positive individuals suggests the risk of cerebral toxoplasmosis in patients that do not have access to HIV treatment. Cerebral toxoplasmosis is one of the sequels of *T.gondii* in HIV patients \[[@CR69]--[@CR71]\], and in the absence of chemo-prophylaxis against HIV, up to 40 % of patients co-infected with *T. gondii* may develop fatal *Toxoplasma* encephalitis \[[@CR6]\]. Before the start of the highly active anti-reteroviral therapy (HAART) in Ethiopia, neural toxoplasmosis was one of the complications \[[@CR72]\] with mortality in more than a third of the patients \[[@CR72], [@CR73]\], and after the initiation of HAART, immune reconstitution inflammatory syndrome (IRIS) was one of the sequels of toxoplasmosis \[[@CR74]--[@CR76]\].

To date, there have been only two studies that reported the prevalence of *T.gondii* in patients with schizophrenia/ bipolar disorders and the study level estimates were greater than 88 % \[[@CR47], [@CR49]\]. Meta-analytical studies have also shown higher odds of schizophrenia (OR = 2.73) \[[@CR77], [@CR78]\], and epilepsy (OR = 4.8) \[[@CR13]\] in *T.gondii* seropositive than in seronegative individuals, and positive associations of *T.gondii* seroprevalence with traffic accidents \[[@CR79]--[@CR81]\], and suicide attempts and success \[[@CR82]\] have been recorded elsewhere.

Implications and limitations {#Sec18}
----------------------------

This study demonstrates the importance of toxoplasmosis in small ruminant production and its public health impact. The control of the disease in a country where most cats are stray, and the food animal management system is mainly of an extensive type is difficult. Therefore, public education as regards the value of cooked meat and washed vegetables, and hygienic practice could reduce the transmission of the parasite and the consequences of infection in humans. Secondly, although a large scale neonatal screening program and treatment of infected neonates at a national level is not an economically viable strategy against congenital infections, initiation of such a program at least in urban areas where there are individuals who afford the medical costs could somehow reduce the impacts of the disease to a limited extent.

As the numbers of eligible studies in each stratum were small and all regions of the country have not been covered in the studies, the estimates and the predictive values of the risk factors may vary depending on factors that may involve animal, environmental and societal variables. However, the pooled estimates highlight the overall magnitude of *Toxoplasma* infections in animals and humans in Ethiopia; the heterogeneity statistics show the variability of the study level estimates and potential areas of research, and the crude odds ratios depict the relative importance of the risk factors.

Conclusions {#Sec19}
===========

Toxoplasmosis is highly prevalent in Ethiopia, and could be a cause of considerable reproductive wastage in small ruminants and multiple diseases in humans. Educational programs, and serological screening and treatment of neonates when possible could help to reduce the national impacts of the disease. Further studies are needed to describe the epidemiology of the disease at a national level in Ethiopia.
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